William J. Febbo - 14 Feb 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Feb 2025, 13:40:27 UTC
Prior SEC filing
16 Dec 2024
Next SEC filing
16 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marion Odence-Ford, by Power of Attorney

Key filing fact

William J. Febbo filed Form 4 for OptimizeRx Corp (OPRX) on 20 Feb 2025.

Key facts

  • This page summarizes William J. Febbo's Form 4 filing for OptimizeRx Corp (OPRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Feb 2025, 13:40.

Change

  • Previous filing in this sequence was filed on 16 Dec 2024.
  • Current net transaction value: -$2,663.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPRX transaction

Common Stock

Tax liability

Transaction value
$2,663
Shares
-401
Change %
-0.07%
Price
$6.64
Shares after
600,852
Date
14 Feb 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC remarks

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .